Mallinckrodt Hospital Products Inc.: Drug Recall

Recall #D-0340-2024 · 02/06/2024

Class II: Risk

Recall Details

Recall Number
D-0340-2024
Classification
Class II
Product Type
Drug
Recalling Firm
Mallinckrodt Hospital Products Inc.
Status
Ongoing
Date Initiated
02/06/2024
Location
Bridgewater, NJ, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8 vials involved in recall (16,479 vials distributed)

Reason for Recall

cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.

Product Description

Acthar Gel (repository corticotropin injection) 400 USP units/5mL (80 USP units/mL), 5mL multiple-dose vial, Rx only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1

Distribution Pattern

USA nationwide

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.